Thursday, January 10, 2013


EPERISONE Hydrochloride
50mg Tablet

DRUG CATEGORY: Muscle Relaxant


FORMULATION: Each white sugar-coated tablet contains 50mg of eperisone hydrochloride.

  1. Dosage form: Sugar-coated tablets
  1. Appearance:
  • Face: 7.5mm in diameter
  • Weight : 162mg
  • Thickness: 4.2mm
  1. Description: White

  • Spastic paralysis in the following diseases:
    • Cerebrovascular diseases, spastic spinal paralysis, cervical spondylosis, post-operative sequelae (including cerebrospinal tumor), sequelae to trauma (spinal trauma, head injury), amytrophic lateral sclerosis, cerebral palsy, spinocerebellar degeneration, spinal vascular diseases, and other encephalomyelopathies.
  • Improvement of myotonic symptoms in the following diseases:
    • Cervical syndrome, periathritis of the shoulder, lumbago.
  • Tension type headache.

The usual adult dose for oral use is 3 tablets (150mg of eperisone hydrochloride) daily in three divided doses after meals. The dose may be adjusted depending on the patient's age and symptoms.

Patients with a history of hypersensitivity to any ingredients of Eperisone hydrochloride.

  1. Careful Administration
  • Patients with a history of drug hypersensitivity
  • Patients with hepatic function disorder (Eperisone hydrochloride may aggravate hepatic function.)
  1. Important Precautions
    Weakness, light-headedness, sleepiness or other symptoms may occur. In the event of such symptoms, the dosage should be reduced or treatment discontinued. Patients should be cautioned against engaging in potentially hazardous activities requiring alertness, such as operating machinery or driving a car.

Precautions for co-administration ( Eperisone hydrochloride should be administered with care when co-administered with the following drugs.)

Methocarbamol: It has been reported that disturbance of visual accomodation occurred after the concommitant use of methocarbamol with tolperisone hydrochloride, an analogue compound. Mechanism is unknown.

Since the elderly often have a physiological hypofunction, it is advisable to take such measures as the reduction in dosage under careful supervision.

  1. Use During Pregnancy
    Eperisone hydrochloride should only be used in pregnant women suspected of being pregnant, if the expected therapeutic benefits are evaluated to outweigh the possible risk of treatment.
  1. Use During Lactation
    It is advisable to avoid the administration of Eperisone hydrochloride to nursing mothers. When Eperisone hydrochloride must be used, breastfeeding should be discontinued during treatment. (It has been reported that Eperisone hydrochloride is excreted in breast milk in an animal study in rats.)

Safety in children has not been established (insufficient clinical experience).

Adverse reactions were reported in 416 of 12,315 patients (3.38%). (At the end of the re-examination period)
  1. Clinically significant adverse reactions (incidence unknown)
  • Shock and anaphylactoid reactions
    Since shock and anaphylactoid reactions may occur, patients should be carefully observed. In the event of symptoms such as redness, itching, urticaria, edema of the face or other parts and dyspnea etc., treatment should be discontinued and appropriate measures taken.
  • Oculo-muco-cutaneous syndrome (Stevens-Johnson sydrome) and toxic epidermal necrolysis (Lyell syndrome)
    Serious dermatopathy such as oculo-muco-cutaneous syndrome (Stevens-Johnson syndrome) or toxic epidermal necrolysis (Lyell syndrome) may occur. Patients should be carefully observed, treatment discontinued and appropriate measures taken, in the event of symptoms such as fever, erythema, blistering, itching, ocular congestion or stomatitis, etc.
  1. Other adverse reactions

Incidence unknown
Hepatic note 1

Elevations of AST (GOT), ALT (GPT) and AI-P, etc.

Renal note 1

Proteinuria and Elevation of BUN, etc.

Hematologic note 1


Hypersensitivity note 2
Erythema exudativum multiforme
Sleepiness, insomnia, headache and numbness in the extremities
Stiffness and temor in the extremities

Nausea/vomiting, anorexia, stomach discomfort, abdominal pain, diarrhea, constipation and thirst
Stomatitis and feeling of enlarged abdomen


Urinary retention, urinary incontinence and feeling of residual urine

Weakness, light-headedness and generalized fatigue
Muscle hypotonia and dizziness

Hot flushes
Diaphoresis and edema

Note 1) Since these symptoms may occur, patients should be carefully observed in the event of such abnormalities, treatment should be discontinued and appropriate measure taken.
Note 2) In the event of such symptoms, treatment should be discontinued.

Blood Concentration
Eperisone hydrochloride was administered orally to 8 healthy adult male volunteers at a single dose of 150 mg/day* for 14 consecutive days and the plasma concentration was determined at days 1, 8 and 14. The time to reach the peak plasma concentration (tmax) ranged from 1.6 to 1.9 hr, the peak plasma concentration (Cmax) was 7.5 to 7.9 ng/ml, elimination half-life (t1/2) was 1.6 to 1.8 hr, and the area under the plasma concentration-time curve (AUC) was 19.7 to 21.1 The plasma concentration profiles of eperisone hydrochloride determined at days 8 to 14 did not significantly vary from those of the first day.

Plasma concentration of eperisone hydrochloride in the course of oral administration at a single dose of 150 mg/day* for 14 consecutive days (means± S.E., n=8)

*A single dose of 150mg is unapproved.

  1. Skeletal muscle relaxation
  • Inhibition of experimentally-induced muscle rigidity
    • Eperisone hydrochloride suppresses intercollicular section-induced decerebrate rigidity (γ-rigidity) and ischemic decerebrate rigidity (α-rigidity) in rats dose-dependently.
  • Suppression of spinal reflexes
    • In spinal cats, eperisone hydrochloride suppresses mono- and polysynaptic reflex potentially induced through spinal nerve efferent root stimulation to a similar degree.
  • Reduction of muscle spindle via γ-motor neurons.
    • Eperisone of muscle suppresses the activity of afferent fibers (Ia fibers) from human spindles at 20min. After administration. Eperisone hydrochloride suppresses the spontaneous discharge of γ-motor neurons, but does not act directly on muscle spindles in animals. Accordingly, eperisone hydrochloride reduces muscle spindle via the γ-motor neurons.
  1. Vasodilation and Augmentation of blood flow
  • Vasodilatory action
    • Eperisone hydrochloride dilates the blood vessels due to Ca++ -antagonistic action (in guinea pigs) on the vascular smooth muscle and muscular sympatholytic actions (in humans).
  • Augmentation of blood flow
    • Eperisone hydrochloride increases the volume of blood flow in skin, muscle, external and internal carotid arteries and vertebral arteries in humans, monkeys and dogs.
  1. Analgesic action and inhibition of the pain reflex in the spinal cord
    When eperisone hydrochloride is perfused into the spinal cord of rats, a tail pinch-induced pain reflex is suppressed, but the reflex returns with the withdrawal of eperisone hydrochloride. This suggests that eperisone hydrochloride possesses an analgesic action at the spinal cord leve.

  1. Facilitation of voluntary movement
    When eperisone hydrochloride is used in the treatment of spastic paralysis in patients with cerebral apoplexy, it improves the cybex torque curve and electromyogram and facilities voluntary movements, such as extension and flexion of the extremities, without reducing the muscular force.

  1. Cervical syndrome, periathritis of the shoulder and lumbago
    In open-labeled clinical trials and a double-blind controlled clinical trial undertaken to determine the effects of Eperisone hydrochloride on myotonic symptoms associated with these diseases, an efficacy rate of 52.1% (234/449) was achieved. (When fairly effective responses are included, the efficacy rate was as high as 80.4%)
  1. Spastic paralysis
    In open-labeled clinical trials and a double-blind trial, the usefulness of Eperisone hydrochloride has been established for spastic paralysis associated with diseases such as cerebrovascular disturbance, spastic spinal paralysis or cervical spondylosis. Improvement rates for rigidity and stiffness in patients with spastic paralysis were 42.3% (197/466) and 45.1% (174/386), respectively.

Eperisone hydrochloride should be stored at temperatures not exceeding 30oC, and should be protected from moisture after opening package.

1 comment:

  1. I was asked by a medical doctor Nicola Whitehill to purchase Dr Itua herbal medicine for Scleroderma as June is Scleroderma month. It took a lot to go through and remember that I have been through a lot! I have learned a lot about herbal medicines and my fight to have a healthy lifestyle! I have recommended Dr Itua herbal medicines to a lot of people so that they can see that the fight may be hard at times, but it is all worth it! You are worth the fight, so don't ever give up and continue to be your own advocate and you may need to switch doctors to get the best care for your body! Keep your head up and keep moving forward despite the obstacle that you may be on! God only gives you what He can handle, so put your faith, trust, and hope in Him and ask Him to show you the direction in which He wants you to go! By researching and finding what you are putting in or on your body can help tremendously and help you to use Food as Medicine to help heal your gut!
    Dr Itua has all types of herbal medicines to cure all kinds of disease such as Herpes,Diabetes,HPV,Copd,Als,Ms,HIV,Cancers,hepatitis,Parkinson,Infertility and other human disease and infections you may have been going through in your life Dr Itua will prepare you a permanent cure.
    Dr Itua herbal center email contact:


Related Posts Plugin for WordPress, Blogger...